Kinetics of TCR use in response to repeated epitope-specific immunization

Journal of Immunology

Volumn 166, Issue 9, 2001, Pages 5817-5825

  Monsurro V ^a   Nielsen, M B ^a   Perez Diez, A ^a   Dudley, M E ^a   Wang, E ^a   Rosenberg, S A ^a   Marincola, F M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; T LYMPHOCYTE RECEPTOR;

ARTICLE; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOCOMPETENCE; IMMUNOGENICITY; MELANOMA; PRIORITY JOURNAL; RECEPTOR AFFINITY;

EID: 0035340516     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.9.5817     Document Type: Article

References (45)

1. Cancer vaccines based on the identification of genes encoding cancer regression antigens
2. Tumor antigens recognized by T cells
3. Immunologic and therapeutic evaluation of a synthetic tumor associated peptide vaccine for the treatment of patients with metastatic melanoma
4. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1
5. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
6. Activation or frustration of anti-tumor responses by T-cell-based immune modulation
7. Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL
8. Is cancer dangerous to the immune system?
9. Immune surveillance against a solid tumor fails because of immunological ignorance
10. A kinetic basis for T cell receptor repertoire selection during an immune response
11. Increased vaccine-specific T cell frequency after peptide-based vaccination correlates with increased susceptibility to in vitro stimulation but does not lead to tumor regression
12. Phototyping: Comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP)
13. T-cell clones from melanoma patients immunized against an anchor modified gp100 peptide display discordant effector phenotypes
14. Therapeutic reconstitution of human viral immunity by adoptive transfer of cytotoxic T lymphocyte clones
15. Phenotypic analysis of antigen-specific T lymphocytes
16. High fidelity mRNA amplification for gene profiling using cDNA microarrays
17. Functional analysis of antigen-specific T lymphocytes by serial measurement of gene expression in peripheral blood mononuclear cells and tumor specimens
18. Functional dissociation between local and systemic immune response following peptide vaccination
19. Improved induction of melanoma reactive CTL with peptides from the melanoma antigen gp 100 modified at HLA-A*0201 binding residues
20. Recognition of multiple epitopes in the human melanoma antigen gp 100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression
21. + T cells
22. Clonal deletion of thymocytes as a tumor escape mechanism
23. Enhanced tumor outgrowth after peptide vaccination: Functional deletion of tumor-specific CTL induced by peptide vaccination can lead to the inability to reject tumors
24. Homeostasis and self-tolerance in the immune system: Turning lymphocytes off
25. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells
26. Replicative senescence of T cells: Does the Hayflick Limit lead to immune exhaustion?
27. + cell subset in HIV disease implicate replicative senescence in HIV pathogenesis
28. Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction
29. + T cells during an acute virus infection
30. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA
31. + T cells in individuals receiving highly active antiretroviral therapy (HAART)
32. + T cells with soluble HLA-A2/Tax 11-19 tetramer complexes in patients with human T cell lymphotropic vires-associated myelopathy
33. + T cells specific for EBV in healthy virus carders
34. + T cells during the primary immune response to Epstein-Barr vires in vivo
35. The effect of infection on T lymphocyte subpopulations: A preliminary report
36. + T cells in acute infectious mononucleosis
37. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
38. Antigen-specific development of primary and memory T cells in vivo
39. Evolution of a complex T cell receptor repertoire during primary and recall bacterial infection
40. k complexes: Correlation of the dissociation rate with T-cell responsiveness
41. The immunological synapse: A molecular machine controlling T cell activation
42. T-cell clonality in immune responses
43. T-cell clonality in immune responses
44. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes
45. Viral immune evasion due to persistence of activated T cells without effector function